600867 通化东宝
已收盘 04-30 15:00:00
资讯
新帖
简况
通化东宝(600867)2026年一季报简析:营收净利润同比双双增长
证券之星 · 04-30 06:09
通化东宝(600867)2026年一季报简析:营收净利润同比双双增长
图解通化东宝一季报:第一季度单季净利润同比增长16.15%
证券之星 · 04-28 18:54
图解通化东宝一季报:第一季度单季净利润同比增长16.15%
通化东宝(600867)3月31日股东户数10.32万户,较上期增加20.31%
证券之星 · 04-28 17:33
通化东宝(600867)3月31日股东户数10.32万户,较上期增加20.31%
每周股票复盘:通化东宝(600867)2025年净利12.19亿拟10派3
证券之星 · 04-26
每周股票复盘:通化东宝(600867)2025年净利12.19亿拟10派3
通化东宝扭亏背后:一次性的“财技”与尚未修复的盈利能力
新浪证券 · 04-24
通化东宝扭亏背后:一次性的“财技”与尚未修复的盈利能力
通化东宝扭亏背后:七成利润靠“卖子”,毛利率承压向GLP-1赛道求增长
蓝鲸财经 · 04-21
通化东宝扭亏背后:七成利润靠“卖子”,毛利率承压向GLP-1赛道求增长
通化东宝(600867)2025年年报简析:营收净利润同比双双增长
证券之星 · 04-21
通化东宝(600867)2025年年报简析:营收净利润同比双双增长
通化东宝(600867)披露2025年年度报告,4月20日股价下跌0.69%
证券之星 · 04-20
通化东宝(600867)披露2025年年度报告,4月20日股价下跌0.69%
股市必读:通化东宝年报 - 第四季度单季净利润同比下降31.12%
中金财经 · 04-20
股市必读:通化东宝年报 - 第四季度单季净利润同比下降31.12%
通化东宝(600867)3月31日股东户数10.32万户,较上期增加20.31%
证券之星 · 04-19
通化东宝(600867)3月31日股东户数10.32万户,较上期增加20.31%
图解通化东宝年报:第四季度单季净利润同比下降31.12%
证券之星 · 04-19
图解通化东宝年报:第四季度单季净利润同比下降31.12%
每周股票复盘:通化东宝(600867)回购进展显示已耗资2757万
证券之星 · 04-05
每周股票复盘:通化东宝(600867)回购进展显示已耗资2757万
通化东宝(600867)披露以集中竞价交易方式回购公司股份进展公告,4月2日股价上涨1.67%
证券之星 · 04-02
通化东宝(600867)披露以集中竞价交易方式回购公司股份进展公告,4月2日股价上涨1.67%
3月30日通化东宝涨7.19%,博时中证1000指数增强A基金重仓该股
证券之星 · 03-30
3月30日通化东宝涨7.19%,博时中证1000指数增强A基金重仓该股
股市必读:通化东宝(600867)3月23日收盘跌5.7%,主力净流出662.74万元
证券之星 · 03-24
股市必读:通化东宝(600867)3月23日收盘跌5.7%,主力净流出662.74万元
每周股票复盘:通化东宝(600867)回购进展支付超2757万元
证券之星 · 02-08
每周股票复盘:通化东宝(600867)回购进展支付超2757万元
通化东宝收警示函背后:控股股东质押率超94%,12亿净利难掩转型焦虑
市场资讯 · 02-04
通化东宝收警示函背后:控股股东质押率超94%,12亿净利难掩转型焦虑
2月2日通化东宝跌5.30%,博时中证1000指数增强A基金重仓该股
证券之星 · 02-02
2月2日通化东宝跌5.30%,博时中证1000指数增强A基金重仓该股
通化东宝药业被责令改正,董事长被出具警示函,涉独立性不足
蓝鲸财经 · 02-01
通化东宝药业被责令改正,董事长被出具警示函,涉独立性不足
每周股票复盘:通化东宝(600867)2025年预盈12.42亿元
证券之星 · 02-01
每周股票复盘:通化东宝(600867)2025年预盈12.42亿元
加载更多
公司概况
公司名称:
通化东宝药业股份有限公司
所属行业:
医药制造业
上市日期:
1994-08-24
主营业务:
通化东宝药业股份有限公司的主营业务是糖尿病及内分泌治疗领域生物制品、中成药、化学药等药品的研发、生产和销售。公司的主要产品是人胰岛素原料药、人胰岛素注射剂、甘精胰岛素原料药、甘精胰岛素注射液、门冬胰岛素原料药、门冬胰岛素注射液、预混型门冬胰岛素、利拉鲁肽注射液、恩格列净片、镇脑宁胶囊、糖尿病相关的医疗器械。公司拥有国家级企业技术中心、国家GMP和欧盟GMP认证的生产车间。被国家认定为高新技术企业、国家技术创新示范企业、ISO14001环境体系认证企业。
发行价格:
6.50
{"stockData":{"symbol":"600867","market":"SH","secType":"STK","nameCN":"通化东宝","latestPrice":9.23,"timestamp":1777532400000,"preClose":9.56,"halted":0,"volume":58599382,"delay":0,"changeRate":-0.0345,"floatShares":1959000000,"shares":1959000000,"eps":0.6315,"marketStatus":"已收盘","change":-0.33,"latestTime":"04-30 15:00:00","open":9.5,"high":9.53,"low":9.19,"amount":545000000,"amplitude":0.0356,"askPrice":9.24,"askSize":741,"bidPrice":9.23,"bidSize":483,"shortable":0,"etf":0,"ttmEps":0.6315,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778031000000},"marketStatusCode":5,"adr":0,"adjPreClose":9.56,"symbolType":"stock","openAndCloseTimeList":[[1777512600000,1777519800000],[1777525200000,1777532400000]],"highLimit":10.52,"lowLimit":8.6,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1958542829,"isCdr":false,"pbRate":2.5,"roa":"--","peRate":14.615994,"roe":"1.77%","epsLYR":0.62,"committee":0.480989,"marketValue":18077000000,"turnoverRate":0.0299,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-05-06。","floatMarketCap":18077000000},"requestUrl":"/m/hq/s/600867","defaultTab":"news","newsList":[{"id":"2631527761","title":"通化东宝(600867)2026年一季报简析:营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2631527761","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631527761?lang=zh_cn&edition=full","pubTime":"2026-04-30 06:09","pubTimestamp":1777500567,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期通化东宝发布2026年一季报。根据财报显示,通化东宝营收净利润同比双双增长。截至本报告期末,公司营业总收入7.48亿元,同比上升14.76%,归母净利润1.27亿元,同比上升16.16%。去年的净利率为40.62%,算上全部成本后,公司产品或服务的附加值极高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000018965.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630303336","title":"图解通化东宝一季报:第一季度单季净利润同比增长16.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630303336","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630303336?lang=zh_cn&edition=full","pubTime":"2026-04-28 18:54","pubTimestamp":1777373649,"startTime":"0","endTime":"0","summary":"证券之星消息,通化东宝2026年一季报显示,一季度公司主营收入7.48亿元,同比上升14.76%;归母净利润1.27亿元,同比上升16.16%;扣非净利润1.27亿元,同比上升15.72%;负债率12.27%,投资收益1203.71万元,财务费用282.64万元,毛利率71.62%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800054718.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630937483","title":"通化东宝(600867)3月31日股东户数10.32万户,较上期增加20.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630937483","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630937483?lang=zh_cn&edition=full","pubTime":"2026-04-28 17:33","pubTimestamp":1777368828,"startTime":"0","endTime":"0","summary":"证券之星消息,近日通化东宝披露,截至2026年3月31日公司股东户数为10.32万户,较12月31日增加1.74万户,增幅为20.31%。在生物制品行业个股中,通化东宝股东户数高于行业平均水平,截至3月31日,生物制品行业平均股东户数为3.56万户。从股价来看,2025年12月31日至2026年3月31日,通化东宝区间涨幅为16.16%,在此期间股东户数增加1.74万户,增幅为20.31%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800051466.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600867","BK0196","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630580452","title":"每周股票复盘:通化东宝(600867)2025年净利12.19亿拟10派3","url":"https://stock-news.laohu8.com/highlight/detail?id=2630580452","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630580452?lang=zh_cn&edition=full","pubTime":"2026-04-26 03:30","pubTimestamp":1777145429,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘,通化东宝报收于9.61元,较上周的10.15元下跌5.32%。本周,通化东宝4月20日盘中最高价报10.33元。本周关注点来自业绩披露要点:通化东宝2025年归母净利润12.19亿元,实现扭亏为盈。该方案尚需提交公司2025年年度股东大会审议。股权登记日为2026年5月6日,登记时间截至2026年5月11日。报告期间为2025年1月1日至12月31日,主体范围包括公司及子公司。2025年实际发生关联交易总额6,261.16万元,未超过预计总额7,395.00万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600001420.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0188","BK0239","600867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629815121","title":"通化东宝扭亏背后:一次性的“财技”与尚未修复的盈利能力","url":"https://stock-news.laohu8.com/highlight/detail?id=2629815121","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629815121?lang=zh_cn&edition=full","pubTime":"2026-04-24 16:04","pubTimestamp":1777017840,"startTime":"0","endTime":"0","summary":"一份归母净利润大涨、成功扭亏的年报,让通化东宝看上去已走出胰岛素集采的阴影。但若拨开非经常性损益的“外衣”,公司真实的主业修复远未达到市场期待的水平——扣非净利润与归母净利润之间超过8亿元的落差,揭示出这家老牌糖尿病药企仍面临不小的经营压力。 通化东宝的2025年年报,表面上是扭亏为盈的转折点,实则是一次性收益修饰后的“账面修复”。在那之前,通化东宝的“修复”故事,还缺少最关键的一章。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-04-24/doc-inhvqwee3156766.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0188","600867","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629087564","title":"通化东宝扭亏背后:七成利润靠“卖子”,毛利率承压向GLP-1赛道求增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2629087564","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629087564?lang=zh_cn&edition=full","pubTime":"2026-04-21 18:08","pubTimestamp":1776766110,"startTime":"0","endTime":"0","summary":"但在胰岛素集采续约的价格压力以及GLP-1赛道日益激烈的存量博弈下,通化东宝未来的增长故事恐难一帆风顺。报告期内,通化东宝胰岛素类似物销量同比增长超100%,制剂收入首次超越人胰岛素,成为第一大收入来源。GLP-1赛道拥挤,利拉鲁肽出海在胰岛素业务面临增长瓶颈之际,通化东宝试图通过GLP-1受体激动剂开辟第二增长曲线。通化东宝方面表示。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1776764139539784528","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK0239","BK0196","BK4144","GLP","BK4590","BK0188","600867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629714747","title":"通化东宝(600867)2025年年报简析:营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2629714747","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629714747?lang=zh_cn&edition=full","pubTime":"2026-04-21 06:02","pubTimestamp":1776722542,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期通化东宝发布2025年年报。根据财报显示,通化东宝营收净利润同比双双增长。截至本报告期末,公司营业总收入29.47亿元,同比上升46.66%,归母净利润12.19亿元,同比上升3005.63%。所得税费用变动幅度为381.31%,原因:报告期营业收入增长及转让特宝生物股份导致利润总额增长,且上年同期亏损。营业成本变动幅度为66.72%,原因:报告期公司胰岛素系列产品销量较同期增长显著,其营业收入大幅增加,营业成本随之变动。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042100010432.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628454967","title":"通化东宝(600867)披露2025年年度报告,4月20日股价下跌0.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628454967","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628454967?lang=zh_cn&edition=full","pubTime":"2026-04-20 17:13","pubTimestamp":1776676397,"startTime":"0","endTime":"0","summary":"截至2026年4月20日收盘,通化东宝报收于10.08元,较前一交易日下跌0.69%,最新总市值为197.42亿元。该股当日开盘10.17元,最高10.33元,最低9.99元,成交额达6.89亿元,换手率为3.49%。公司于近日披露《通化东宝药业股份有限公司2025年年度报告》。公司拟向全体股东每10股派发现金红利3.00元(含税),合计拟派发现金红利586,837,503.60元(含税),现金分红占2025年度归属于上市公司股东净利润的比例为48.14%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000023345.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","600867","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628794569","title":"股市必读:通化东宝年报 - 第四季度单季净利润同比下降31.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628794569","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628794569?lang=zh_cn&edition=full","pubTime":"2026-04-20 07:36","pubTimestamp":1776641814,"startTime":"0","endTime":"0","summary":"来自:截至2026年3月31日公司股东户数增至10.32万户,环比增长20.31%。来自:通化东宝2025年归母净利润达12.19亿元,同比上升3005.63%,实现扭亏为盈。 近日通化东宝披露,截至2026年3月31日公司股东户数为10.32万户,较12月31日增加1.74万户,增幅为20.31%。通化东宝2025年年度利润分配方案公告。通化东宝第十一届董事会第二十四次会议决议公告","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260420/32155762.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["600867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628769648","title":"通化东宝(600867)3月31日股东户数10.32万户,较上期增加20.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628769648","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628769648?lang=zh_cn&edition=full","pubTime":"2026-04-19 17:03","pubTimestamp":1776589425,"startTime":"0","endTime":"0","summary":"证券之星消息,近日通化东宝披露,截至2026年3月31日公司股东户数为10.32万户,较12月31日增加1.74万户,增幅为20.31%。在生物制品行业个股中,通化东宝股东户数高于行业平均水平,截至3月31日,生物制品行业平均股东户数为3.53万户。从股价来看,2025年12月31日至2026年3月31日,通化东宝区间涨幅为16.16%,在此期间股东户数增加1.74万户,增幅为20.31%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900008082.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0239","600867","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628766098","title":"图解通化东宝年报:第四季度单季净利润同比下降31.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628766098","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628766098?lang=zh_cn&edition=full","pubTime":"2026-04-19 16:33","pubTimestamp":1776587630,"startTime":"0","endTime":"0","summary":"证券之星消息,通化东宝2025年年报显示,当年度公司主营收入29.47亿元,同比上升46.66%;归母净利润12.19亿元,同比上升3005.63%;扣非净利润3.75亿元,同比上升3833.89%;其中2025年第四季度,公司单季度主营收入7.68亿元,同比上升36.62%;单季度归母净利润1681.85万元,同比下降31.12%;单季度扣非净利润5359.93万元,同比上升136.94%;负债率10.1%,投资收益11.8亿元,财务费用1874.34万元,毛利率70.33%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900006334.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625861520","title":"每周股票复盘:通化东宝(600867)回购进展显示已耗资2757万","url":"https://stock-news.laohu8.com/highlight/detail?id=2625861520","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625861520?lang=zh_cn&edition=full","pubTime":"2026-04-05 01:33","pubTimestamp":1775323990,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘,通化东宝报收于9.9元,较上周的8.9元上涨11.24%。本周,通化东宝4月3日盘中最高价报10.26元,股价触及近一年最高点。本周关注点公司公告汇总:截至2026年3月末,公司已累计回购股份3,000,000股,耗资27,574,286.00元。公司公告汇总通化东宝药业股份有限公司于2025年10月17日召开董事会审议通过回购股份方案,拟使用自有资金以集中竞价交易方式回购股份,用于员工持股计划或股权激励。上述进展符合相关规定及回购方案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040500000221.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0196","600867","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624550781","title":"通化东宝(600867)披露以集中竞价交易方式回购公司股份进展公告,4月2日股价上涨1.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624550781","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624550781?lang=zh_cn&edition=full","pubTime":"2026-04-02 22:11","pubTimestamp":1775139079,"startTime":"0","endTime":"0","summary":"截至2026年4月2日收盘,通化东宝报收于9.75元,较前一交易日上涨1.67%,最新总市值为190.96亿元。该股当日开盘9.63元,最高9.86元,最低9.51元,成交额达10.12亿元,换手率为5.33%。通化东宝于2026年4月2日发布《关于以集中竞价交易方式回购公司股份进展公告》。公告显示,公司于2025年10月17日召开董事会审议通过回购股份方案,拟使用自有资金以集中竞价交易方式回购股份,用于员工持股计划或股权激励。上述进展符合相关规定及回购方案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200041994.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0196","600867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623397499","title":"3月30日通化东宝涨7.19%,博时中证1000指数增强A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2623397499","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623397499?lang=zh_cn&edition=full","pubTime":"2026-03-30 16:23","pubTimestamp":1774858984,"startTime":"0","endTime":"0","summary":"证券之星消息,3月30日通化东宝涨7.19%创60日新高,收盘报9.54元,换手率5.97%,成交量116.94万手,成交额11.07亿元。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共3家,其中持有数量最多的公募基金为博时基金的博时中证1000指数增强A。博时中证1000指数增强A目前规模为3.89亿元,最新净值1.5904,较上一交易日上涨1.22%,近一年上涨30.82%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000021263.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159967","000688.SH","512510","BK0188","BK0239","510880","512880","399001","515890","000905.SH","399006","600867","BK0196","510300","000300.SH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621089876","title":"股市必读:通化东宝(600867)3月23日收盘跌5.7%,主力净流出662.74万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621089876","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621089876?lang=zh_cn&edition=full","pubTime":"2026-03-24 03:04","pubTimestamp":1774292656,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘,通化东宝报收于8.11元,下跌5.7%,换手率2.27%,成交量44.48万手,成交额3.65亿元。交易信息汇总股价提醒3月23日通化东宝收盘报8.11元,跌5.7%,当日成交4447.93万元。该股已连续3日下跌。前10个交易日中,主力资金累计净流出7526.84万元,股价累计下跌8.44%;融资余额累计减少1095.79万元,融券余量累计减少2.94万股。最近90天内,共有3家机构对该股给出买入评级,机构目标均价为10.95元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400002785.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600867","BK0188","BK0196","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609252373","title":"每周股票复盘:通化东宝(600867)回购进展支付超2757万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609252373","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609252373?lang=zh_cn&edition=full","pubTime":"2026-02-08 01:30","pubTimestamp":1770485432,"startTime":"0","endTime":"0","summary":"截至2026年2月6日收盘,通化东宝报收于8.91元,较上周的9.05元下跌1.55%。本周,通化东宝2月5日盘中最高价报9.24元。本周关注点公司公告汇总:截至2026年1月末,累计支付27,574,286.00元回购股份公司公告汇总通化东宝药业股份有限公司于2025年10月17日召开董事会,审议通过以集中竞价交易方式回购公司股份的方案,回购资金总额不低于2,000万元且不超过4,000万元,回购价格不超过10元/股,回购期限为2025年10月17日至2026年4月16日。上述进展符合相关规定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020800000268.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0196","600867","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608552053","title":"通化东宝收警示函背后:控股股东质押率超94%,12亿净利难掩转型焦虑","url":"https://stock-news.laohu8.com/highlight/detail?id=2608552053","media":"市场资讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608552053?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:01","pubTimestamp":1770192060,"startTime":"0","endTime":"0","summary":" 2026年1月30日,通化东宝药业股份有限公司发布公告称,收到吉林证监局下发的行政监管措施决定书。决定书指出,通化东宝与控股股东东宝实业集团股份有限公司存在部分房产互相混用情况,双方未签订相关租赁协议,也未支付租金。吉林证监局决定对公司采取责令改正措施,对董事长李佳鸿出具警示函,并将相关情况记入证券期货市场诚信档案。 通化东宝与控股股东之间的房产混用问题,暴露出公司在独立性方面的缺陷。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2026-02-04/doc-inhkrtwm6663771.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["600867","BK0188","BK0239","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608185904","title":"2月2日通化东宝跌5.30%,博时中证1000指数增强A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2608185904","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608185904?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:35","pubTimestamp":1770021303,"startTime":"0","endTime":"0","summary":"证券之星消息,2月2日通化东宝跌5.30%,收盘报8.57元,换手率3.43%,成交量67.12万手,成交额5.85亿元。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共3家,其中持有数量最多的公募基金为博时基金的博时中证1000指数增强A。博时中证1000指数增强A目前规模为3.89亿元,最新净值1.6771,较上一交易日下跌1.04%,近一年上涨50.8%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200023258.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000905.SH","000300.SH","515890","600867","BK0196","510300","399001","512510","512880","BK0188","510880","BK0239","399006","000688.SH","159967"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608001082","title":"通化东宝药业被责令改正,董事长被出具警示函,涉独立性不足","url":"https://stock-news.laohu8.com/highlight/detail?id=2608001082","media":"蓝鲸财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608001082?lang=zh_cn&edition=full","pubTime":"2026-02-01 16:19","pubTimestamp":1769933978,"startTime":"0","endTime":"0","summary":"蓝鲸新闻2月1日讯,近日,吉林证监局发布行政监管措施决定书,剑指通化东宝药业股份有限公司、李佳鸿。决定书显示,通化东宝药业股份有限公司存在以下问题:通化东宝与控股股东东宝实业集团股份有限公司存在部分房产互相混用情况,双方未签订相关租赁协议,未支付租金。上述事项反映出通化东宝独立性存在不足,违反了《上市公司治理准则》有关规定,公司董事长李佳鸿对上述违规行为负主要责任。对此,吉林证监局决定对通化东宝药业股份有限公司采取责令改正,对李佳鸿采取出具警示函的监督管理措施,并记入证券期货市场诚信档案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1769781247225369242","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["600867","BK0196","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608297072","title":"每周股票复盘:通化东宝(600867)2025年预盈12.42亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608297072","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608297072?lang=zh_cn&edition=full","pubTime":"2026-02-01 01:52","pubTimestamp":1769881930,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘,通化东宝报收于9.05元,较上周的8.9元上涨1.69%。公司公告汇总:公司2025年四季度计提减值损失合计1.34亿元,减少当期利润总额。业绩披露要点通化东宝发布业绩预告,预计2025年全年归属净利润盈利约12.42亿元。公司公告汇总通化东宝预计2025年年度实现归属于母公司所有者的净利润约为124,213万元,与上年同期相比实现扭亏为盈。东宝集团及其一致行动人合计持有公司股份641,362,975股,占公司总股本的32.75%,累计质押股份占其持股总数的91.44%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100000382.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","600867","BK0196"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1777567857242,"stockEarnings":[{"period":"1week","weight":-0.0345},{"period":"1month","weight":-0.0274},{"period":"3month","weight":0.0199},{"period":"6month","weight":0.0221},{"period":"1year","weight":0.3186},{"period":"ytd","weight":0.1297}],"compareEarnings":[{"period":"1week","weight":0.0046},{"period":"1month","weight":0.0566},{"period":"3month","weight":-0.0014},{"period":"6month","weight":0.0398},{"period":"1year","weight":0.2541},{"period":"ytd","weight":0.0361}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"通化东宝药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"103178人(较上一季度增加20.31%)","perCapita":"18982股","listingDate":"1994-08-24","address":"吉林省通化市通化县东宝新村","registeredCapital":"195854万元","survey":" 通化东宝药业股份有限公司的主营业务是糖尿病及内分泌治疗领域生物制品、中成药、化学药等药品的研发、生产和销售。公司的主要产品是人胰岛素原料药、人胰岛素注射剂、甘精胰岛素原料药、甘精胰岛素注射液、门冬胰岛素原料药、门冬胰岛素注射液、预混型门冬胰岛素、利拉鲁肽注射液、恩格列净片、镇脑宁胶囊、糖尿病相关的医疗器械。公司拥有国家级企业技术中心、国家GMP和欧盟GMP认证的生产车间。被国家认定为高新技术企业、国家技术创新示范企业、ISO14001环境体系认证企业。","listedPrice":6.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"通化东宝(600867)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供通化东宝(600867)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"通化东宝,600867,通化东宝股票,通化东宝股票老虎,通化东宝股票老虎国际,通化东宝行情,通化东宝股票行情,通化东宝股价,通化东宝股市,通化东宝股票价格,通化东宝股票交易,通化东宝股票购买,通化东宝股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"通化东宝(600867)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供通化东宝(600867)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}